VITA » Topics » SALES AND MARKETING

These excerpts taken from the VITA 10-K filed Mar 16, 2009.

SALES AND MARKETING

We have a U.S. field sales network of direct sales representatives and independent non-stocking distributors who market VITOSS, VITAGEL, CELLPAKER, IMBIBE and VITASURE products. We continually seek to strengthen our field sales network through the addition of direct sales representatives in those U.S. sales territories where either we do not have independent distributor coverage or the territories are underserved. Outside the U.S., we primarily utilize a network of independent stocking distributors to market VITOSS, CORTOSS, ALIQUOT, VITAGEL, CELLPAKER and VITASURE products.

SALES AND MARKETING

FACE="Times New Roman" SIZE="2">We have a U.S. field sales network of direct sales representatives and independent non-stocking distributors who market VITOSS, VITAGEL, CELLPAKER, IMBIBE and VITASURE products. We continually seek to strengthen our
field sales network through the addition of direct sales representatives in those U.S. sales territories where either we do not have independent distributor coverage or the territories are underserved. Outside the U.S., we primarily utilize a
network of independent stocking distributors to market VITOSS, CORTOSS, ALIQUOT, VITAGEL, CELLPAKER and VITASURE products.

This excerpt taken from the VITA 10-K filed Mar 17, 2008.

SALES AND MARKETING

In June 2003, we began to assemble a U.S. field sales network of direct sales representatives and independent non-stocking distributors who now market VITOSS, VITAGEL, CELLPAKER and IMBIBE. We continually seek to strengthen our field sales network through the addition of direct sales representatives in those U.S. sales territories where either we do not have independent distributor coverage or the territories are underserved. Outside of the U.S., we primarily utilize a network of independent, stocking distributors to market VITOSS, CORTOSS, ALIQUOT, VITAGEL and CELLPAKER.

This excerpt taken from the VITA 10-K filed Mar 16, 2007.

SALES AND MARKETING

In June 2003, we began to assemble a U.S. field sales network of direct sales representatives and independent sales agencies who now market VITOSS, VITAGEL, CELLPAKER and IMBIBE. We continually seek to strengthen our field sales network through the addition of direct sales representatives in those U.S. sales territories where either we do not have independent sales agency coverage or the territories are underserved. Outside of the U.S., we primarily utilize a network of independent, stocking distributors to market VITOSS, CORTOSS, and ALIQUOT.

This excerpt taken from the VITA 10-K filed Mar 16, 2006.

SALES AND MARKETING

In June 2003, we began to assemble a U.S. field sales network of direct sales representatives and independent sales agencies in order to market VITOSS Bone Graft Substitute, VITAGEL and IMBIBE Bone Marrow Aspirate and Delivery Device. We continually seek to strengthen our field sales network through the addition of direct sales representatives in those U.S. sales territories where either we do not have independent sales agency coverage or the territories are under served. Outside of the U.S., we primarily utilize a network of independent, stocking distributors to market VITOSS Bone Graft Substitute, CORTOSS, and ALIQUOT Micro Delivery System.

This excerpt taken from the VITA 10-K filed Mar 16, 2005.

SALES AND MARKETING

 

In June 2003, we began to assemble a U.S. field sales network of direct sales representatives and independent sales agencies in order to market VITOSS Bone Graft Substitute and IMBIBE Bone Marrow Aspirate and Delivery Device. We may further strengthen our field sales network through the addition of direct sales representatives in those U.S. sales territories where either we do not have independent sales agency coverage or the territories are under served. We also utilize our current field sales network to market VITAGEL in the U.S. Outside of the U.S., we primarily utilize a network of independent, stocking distributors to market VITOSS Bone Graft Substitute, CORTOSS, and ALIQUOT Micro Delivery System.

 

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki